EDITORIAL TOPICS
Acute ischaemic stroke: highlighting the need for early intervention.
Cardiomyopathies and myocardial disorders in Africa: present status and the way forward.
Successes, failures, challenges and ground-breaking research: messages from the 6th World Congress of Paediatric Cardiology and Cardiac Surgery.
Cardiomyopathies and myocardial disorders in Africa: present status and the way forward.
Successes, failures, challenges and ground-breaking research: messages from the 6th World Congress of Paediatric Cardiology and Cardiac Surgery.
Updated: 15 May 2013
CARDIOVASCULAR TOPICS
Updated: 15 May 2013
DRUG TRENDS
South African studies in the international
literature.
Higher statin doses linked to acute kidney injury: South African experts comment on clinical implications.
Treating hypertension in the elderly, even white-coat hypertension, is essential.
Use new antiplatelet therapies consistently in clinical practice.
Higher statin doses linked to acute kidney injury: South African experts comment on clinical implications.
Treating hypertension in the elderly, even white-coat hypertension, is essential.
Use new antiplatelet therapies consistently in clinical practice.
Updated: 15 May 2013
CASE REPORTS
Left ventricular non-compaction in pregnancy.
Unusual variant of scimitar syndrome associated with an absent right pulmonary artery, stenosis of the inferior vena cava, hemi-azygous continuation and the VACTERL association.
Unexpected preserved brain perfusion imaging despite severe and diffuse atherosclerosis of supra-aortic trunks.
Unusual variant of scimitar syndrome associated with an absent right pulmonary artery, stenosis of the inferior vena cava, hemi-azygous continuation and the VACTERL association.
Unexpected preserved brain perfusion imaging despite severe and diffuse atherosclerosis of supra-aortic trunks.
Updated: 15 May 2013
ABOUT CARDIOVASCULAR JOURNAL OF AFRICA
The Cardiovascular Journal of Africa (CVJA) is an international
peer-reviewed journal that keeps cardiologists up to
date with advances in the diagnosis and treatment of
cardiovascular disease.
Topics covered include coronary disease, electrophysiology, valve disease, imaging techniques, congenital heart disease (fetal, paediatric & adult), heart failure, surgery, & basic science. CVJA is the official journal of the PASCAR and has been published since 1990.
Topics covered include coronary disease, electrophysiology, valve disease, imaging techniques, congenital heart disease (fetal, paediatric & adult), heart failure, surgery, & basic science. CVJA is the official journal of the PASCAR and has been published since 1990.
LATEST NEWS
Cardiovascular
Journal of Africa: Volume 24, Issue 3, April 2013
• Non-communicable diseases in Uganda
• Selective inhibition of angiotensin II type 1 receptors
• Hypertension and associated factors in older adults
• Neonatal circulatory failure due to hypertensive crisis
• Decreased vascular contractility induced by hemin
• Cardiovascular complications in RHD patients
• Management of acute ischaemic stroke
This journal is now available to be viewed via our eJournal publication viewer.
4th All African Conference on Heart Disease, Diabetes and Stroke
The abstracts for this important conference organised by the Pan African Society of Cardiology (PASCAR) and the Senegalese Society of Cardiology are now available.
Approxomately 120 abstracts highlight the latest research in Africa:
• Recent advances in Cardiovascular Medicine
• Controversies in Cardiac Surgery
• Increasing access to pacemakers and ICDs
• Recent advances in imaging
• Prevention and control of Non-Communicable Diseases
• Management of Heart Disease and Diabetes in Pregnancy
• Guidelines for Management of Common Cardiac Conditions
• Paediatric Cardiology
• Diabetes and Obesity
Download Options:
• Book of Abstracts in PDF format
• Book of Abstracts in ePublication viewer
The Cardiovascular Journal of Africa and invites all delegates to visit our exhibit during breaks and lunch to discuss opportunities to publish your work in the official journal of PASCAR and to register for our Editor’s Choice e-alert.
From the Editor’s Desk: New impact factor and PubMed Central Service from the Cardiovascular Journal of Africa
The Cardiovascular Journal of Africa is pleased to announce an increase in its 2011 impact factor to 0.767, as provided by Thompson Reuters (ISI). Currently, we rank 161 out of 273 indexed journals in the field of cardiology and cardiovascular medicine throughout the world, according to the Scopus journalrating system. The Cardiovascular Journal of Africa is truly entrenched in Africa and worldwide.
In order to improve visibility for our authors, the Cardiovascular Journal of Africa has developed the capability of publishing your article to PubMed Central (PMC), which is the free electronic archive of the Biomedical and Life Sciences Journal literature at the US National Institutes of Health National Library of Medicine (NIH/NLM). Read Full Article »
• Non-communicable diseases in Uganda
• Selective inhibition of angiotensin II type 1 receptors
• Hypertension and associated factors in older adults
• Neonatal circulatory failure due to hypertensive crisis
• Decreased vascular contractility induced by hemin
• Cardiovascular complications in RHD patients
• Management of acute ischaemic stroke
This journal is now available to be viewed via our eJournal publication viewer.
4th All African Conference on Heart Disease, Diabetes and Stroke
The abstracts for this important conference organised by the Pan African Society of Cardiology (PASCAR) and the Senegalese Society of Cardiology are now available.
Approxomately 120 abstracts highlight the latest research in Africa:
• Recent advances in Cardiovascular Medicine
• Controversies in Cardiac Surgery
• Increasing access to pacemakers and ICDs
• Recent advances in imaging
• Prevention and control of Non-Communicable Diseases
• Management of Heart Disease and Diabetes in Pregnancy
• Guidelines for Management of Common Cardiac Conditions
• Paediatric Cardiology
• Diabetes and Obesity
Download Options:
• Book of Abstracts in PDF format
• Book of Abstracts in ePublication viewer
The Cardiovascular Journal of Africa and invites all delegates to visit our exhibit during breaks and lunch to discuss opportunities to publish your work in the official journal of PASCAR and to register for our Editor’s Choice e-alert.
From the Editor’s Desk: New impact factor and PubMed Central Service from the Cardiovascular Journal of Africa
The Cardiovascular Journal of Africa is pleased to announce an increase in its 2011 impact factor to 0.767, as provided by Thompson Reuters (ISI). Currently, we rank 161 out of 273 indexed journals in the field of cardiology and cardiovascular medicine throughout the world, according to the Scopus journalrating system. The Cardiovascular Journal of Africa is truly entrenched in Africa and worldwide.
In order to improve visibility for our authors, the Cardiovascular Journal of Africa has developed the capability of publishing your article to PubMed Central (PMC), which is the free electronic archive of the Biomedical and Life Sciences Journal literature at the US National Institutes of Health National Library of Medicine (NIH/NLM). Read Full Article »
Drug
Trends in Cardiology: Use new antiplatelet therapies
consistently in clinical practice
Optimising the benefits of new anti-platelet therapies in daily clinical practice should be based on selecting the particular agents that the responsible clinician would like to use in managing acute coronary syndrome (ACS) patients and then sticking to this selection. Speaking in Accra, Ghana to African cardiologists and physicians attending a special AstraZeneca-sponsored CME symposium, Prof Jean-Pierre Bassand, past president of the European Society of Cardiology and head of Cardiology at the University of Besancon, Franche-Comte, noted that ‘In my 35 years of experience in cardiology, physicians and nurses respond best when they have a simpler regimen of anti-coagulation and antiplatelet agents to use in the ACS setting.’ Read More »
In memoriam: Tribute to the late Professor Oluwole Ademola Adebo
Oluwole Ademola Adebo was born in Lagos on 16 August 1944, the first son to Chief Simeon and Regina Adebo. As his father was the former head of the Civil Service of the old western region of Nigeria and later United Nations Under-Secretary General, he had the opportunity of travelling extensively around the world and had access to the best education in Nigeria, Europe and the USA.
Prof Adebo started at the University of Ibadan staff primary school and at the age of 11 he moved to the UK for further schooling, where he attended Leighton Park School, Reading and lived with English guardians during the holidays. This perhaps contributed to his being ‘different’ and he was often referred to as ‘oyinbo’ by others. Read More »
Higher statin doses linked to acute kidney injury: South African experts comment on clinical implications
A meta-analysis published this week in the British Medical Journal has linked higher doses of statins (resulting in at least a 45% reduction in low-density lipoprotein cholesterol) to a higher risk of acute kidney injury (AKI) in the first four months of therapy compared to lower-dose statins.
The study was based on data from Canadian, UK and USA databases of some two million patients, where each index case of AKI was matched with 10 controls from the same database and also matched in terms of time of initiation of therapy. Read More »
Simplifying venous thromboembolism management: a new and safer era
Dr Cohen is a vascular physician and epidemiologist involved in clinical work, designing, managing and analysing clinical trials from phase I to IV. He is the chairman and member of many international steering committees for multicentre trials, and epidemiological and pharmaco-economic studies.
He has participated in cardiovascular clinical trials on anticoagulants, thrombolytic agents, and antiplatelet, tihypertensive and lipid-lowering drugs. He has undertaken numerous meta-analyses, economic analyses and large epidemiological studies. Read More »
Optimising the benefits of new anti-platelet therapies in daily clinical practice should be based on selecting the particular agents that the responsible clinician would like to use in managing acute coronary syndrome (ACS) patients and then sticking to this selection. Speaking in Accra, Ghana to African cardiologists and physicians attending a special AstraZeneca-sponsored CME symposium, Prof Jean-Pierre Bassand, past president of the European Society of Cardiology and head of Cardiology at the University of Besancon, Franche-Comte, noted that ‘In my 35 years of experience in cardiology, physicians and nurses respond best when they have a simpler regimen of anti-coagulation and antiplatelet agents to use in the ACS setting.’ Read More »
In memoriam: Tribute to the late Professor Oluwole Ademola Adebo
Oluwole Ademola Adebo was born in Lagos on 16 August 1944, the first son to Chief Simeon and Regina Adebo. As his father was the former head of the Civil Service of the old western region of Nigeria and later United Nations Under-Secretary General, he had the opportunity of travelling extensively around the world and had access to the best education in Nigeria, Europe and the USA.
Prof Adebo started at the University of Ibadan staff primary school and at the age of 11 he moved to the UK for further schooling, where he attended Leighton Park School, Reading and lived with English guardians during the holidays. This perhaps contributed to his being ‘different’ and he was often referred to as ‘oyinbo’ by others. Read More »
Higher statin doses linked to acute kidney injury: South African experts comment on clinical implications
A meta-analysis published this week in the British Medical Journal has linked higher doses of statins (resulting in at least a 45% reduction in low-density lipoprotein cholesterol) to a higher risk of acute kidney injury (AKI) in the first four months of therapy compared to lower-dose statins.
The study was based on data from Canadian, UK and USA databases of some two million patients, where each index case of AKI was matched with 10 controls from the same database and also matched in terms of time of initiation of therapy. Read More »
Simplifying venous thromboembolism management: a new and safer era
Dr Cohen is a vascular physician and epidemiologist involved in clinical work, designing, managing and analysing clinical trials from phase I to IV. He is the chairman and member of many international steering committees for multicentre trials, and epidemiological and pharmaco-economic studies.
He has participated in cardiovascular clinical trials on anticoagulants, thrombolytic agents, and antiplatelet, tihypertensive and lipid-lowering drugs. He has undertaken numerous meta-analyses, economic analyses and large epidemiological studies. Read More »
FIRST ADVANCE ONLINE PUBLICATION (ePUBLICATION AHEAD
OF PRINT)
The Cardiovascular Journal of Africa has launched an
Online First Advance Online Publication (ePublication
ahead of print) with full text availability via Pubmed
and this website which is accessible via Google and
other search engines.
This facility is also known internationally as e-publication, ahead of print and offers authors the opportunity to publish their research articles sooner for an international audience. Read More »
This facility is also known internationally as e-publication, ahead of print and offers authors the opportunity to publish their research articles sooner for an international audience. Read More »
